Tarceva

Active ingredient
Erlotinib
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
484 doctors
Total Number of Patients2
1,408 patients
Total minimum fees planned3
768,500.00 €

Observational Studies including Tarceva

Drug No. of doctors1 No. of patients2 Payment per patient3
Tarceva 38 52 800.00 € 8 Visiten
Tarceva 105 309 600.00 € 150€ Einschluss, 3 Zyklen à 50€, 150€ für weitere Zyklen, 100€ Abschluss, 50€ Patientenbefragung
Tarceva 102 408 600.00 € pro ordnungsgemäß ausgefüllter Patientendokumentation
Tarceva 139 289 300.00 € 300 EUR pro vollständig ausgefüllten Dokumentationsbogen bis 3 Behandlungszyklen, 150 EUR je weitere 3 Behandlungszyklen,150 EUR für weitere zusätzliche Behandlungszyklen bis max. 12 Behandlungszyklen
Tarceva 100 350 600.00 € vollständige Dokumentation mehr als 6 Behandlungszyklen =1 Dokumentation, max. 10 Dokumentationen=€ 6000,- aufgeschlüsselt im Vertrag
Tarceva n/a n/a n/a Meldung vor Anzeigenpflicht

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.